|

Diabetes Clinical Trials in Iowa

31 recruiting studies across 6 cities

All Trials in Iowa

Phase
Trial Phase Location
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes MellitusPhase 3Ames
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or OverweightPhase 3Ames
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes MellitusPhase 3Ames
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes MedicationsPhase 3Council Bluffs
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)Phase 3Des Moines
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 DiabetesPhase 3Iowa City
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and AdultsPhase 3Iowa City
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)Phase 3Iowa City
A Study of Lower Radiotherapy Dose to Treat Children With CNS GerminomaPhase 2Iowa City
Diabetic Foot Ulcer Imaging- Study 2N/AIowa City
Empagliflozin Treatment in Kidney Transplant RecipientsPhase 4Iowa City
IH, Brain Health, and T2DN/AIowa City
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomesPhase 4Iowa City
Metformin for the Treatment of Microvascular Dysfunction After Gestational DiabetesEarly 1Iowa City
Oxidative Stress in Microvascular Dysfunction Following Gestational DiabetesEarly 1Iowa City
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 DiabetesPhase 4Iowa City
Role of ET-1, Physical Activity, and Sedentary Behavior in Microvascular Dysfunction Following GDMEarly 1Iowa City
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)—Iowa City
The Impact of Gestational Diabetes Mellitus on Cerebral Blood Flow and Cerebrovascular Function After PregnancyPhase 1Iowa City
Type 1 Diabetes Extension Study—Iowa City
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes MellitusPhase 3Sioux City
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)Phase 2/3Sioux City
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)Phase 3West Des Moines
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular EventsN/AWest Des Moines
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose WeightPhase 3West Des Moines
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 DiabetesPhase 3West Des Moines
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly IncretinPhase 3West Des Moines
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 ObesityPhase 3West Des Moines
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)Phase 3West Des Moines
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to CagrisemaPhase 3West Des Moines
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)Phase 2West Des Moines

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.